|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shen L, Shan YS, Hu HM, Price TJ, Sirohi
B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, et al: Management of
gastric cancer in Asia: Resource-stratified guidelines. Lancet
Oncol. 14:e535–e547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thrumurthy SG, Chaudry MA, Chau I and
Allum W: Does surgery have a role in managing incurable gastric
cancer? Nat Rev Clin Oncol. 12:676–682. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang G, Fu Y, Liu G, Ye Y and Zhang X:
miR-218 Inhibits Proliferation, Migration, and EMT of Gastric
Cancer Cells by Targeting WASF3. Oncol Res. 25:355–364. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lv H, Zhang Z, Wang Y, Li C, Gong W and
Wang X: MicroRNA-92a promotes colorectal cancer cell growth and
migration by inhibiting KLF4. Oncol Res. 23:283–290. 2016.
View Article : Google Scholar
|
|
9
|
Ji S, Zhang B, Kong Y, Ma F and Hua Y:
miR-326 inhibits gastric cancer cell growth through downregulating
NOB1. Oncol Res. 25:853–861. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang J, Zhang Y, Jiang G, Liu Z, Xiang W,
Chen X, Chen Z and Zhao J: MiR-138 induces renal carcinoma cell
senescence by targeting EZH2 and is downregulated in human clear
cell renal cell carcinoma. Oncol Res. 21:83–91. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He C, Yu T, Shi Y, Ma C, Yang W, Fang L,
Sun M, Wu W, Xiao F, Guo F, et al: MicroRNA 301A promotes
intestinal inflammation and colitis-associated cancer development
by inhibiting BTG1. Gastroenterology. 152:1434–1448.e15. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun HL, Cui R, Zhou J, Teng KY, Hsiao YH,
Nakanishi K, Fassan M, Luo Z, Shi G, Tili E, et al: ERK Activation
globally downregulates miRNAs through phosphorylating exportin-5.
cancer cell. 30:723–736. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jin Y, Tao LP, Yao SC, Huang QK, Chen ZF,
Sun YJ and Jin SQ: MicroRNA-582-5p suppressed gastric cancer cell
proliferation via targeting AKT3. Eur Rev Med Pharmacol Sci.
21:5112–5120. 2017.PubMed/NCBI
|
|
14
|
Qu Y, Zhang H, Sun W, Han Y, Li S, Qu Y,
Ying G and Ba Y: MicroRNA-155 promotes gastric cancer growth and
invasion by negatively regulating transforming growth factor-β
receptor 2. Cancer Sci. 109:618–628. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guan H, Li W, Li Y, Wang J, Li Y, Tang Y
and Lu S: MicroRNA-93 promotes proliferation and metastasis of
gastric cancer via targeting TIMP2. PLoS One. 12:e01894902017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hwang SJ, Lee HW, Kim HR, Song HJ, Lee DH,
Lee H, Shin CH, Joung JG, Kim DH, Joo KM, et al: Overexpression of
microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma
through downregulation of cyclin D1. Oncotarget. 6:20434–20448.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang Z, Huang S, Wang Q, Liang L, Ni S,
Wang L, Sheng W, He X and Du X: MicroRNA-95 promotes cell
proliferation and targets sorting Nexin 1 in human colorectal
carcinoma. Cancer Res. 71:2582–2589. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fan B, Jiao BH, Fan FS, Lu SK, Song J, Guo
CY, Yang JK and Yang L: Downregulation of miR-95-3p inhibits
proliferation, and invasion promoting apoptosis of glioma cells by
targeting CELF2. Int J Oncol. 47:1025–1033. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen J, Sun D, Chu H, Gong Z, Zhang C,
Gong B, Li Y, Li N and Jiang L: Screening of differential microRNA
expression in gastric signet ring cell carcinoma and gastric
adenocarcinoma and target gene prediction. Oncol Rep. 33:2963–2971.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jun KH, Lee JS, Kim JH, Kim JJ, Chin HM
and Park SM: The rationality of N3 classification in the 7th
edition of the International Union Against Cancer TNM staging
system for gastric adenocarcinomas: A case-control study. Int J
Surg. 12:893–896. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen X, Chen S, Hang W, Huang H and Ma H:
MiR-95 induces proliferation and chemo- or radioresistance through
directly targeting sorting nexin1 (SNX1) in non-small cell lung
cancer. Biomed Pharmacother. 68:589–595. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiao Z, Ching Chow S, Han Li C, Chun Tang
S, Tsui SK, Lin Z and Chen Y: Role of microRNA-95 in the anticancer
activity of Brucein D in hepatocellular carcinoma. Eur J Pharmacol.
728:141–150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ng EK, Chong WW, Jin H, Lam EK, Shin VY,
Yu J, Poon TC, Ng SS and Sung JJ: Differential expression of
microRNAs in plasma of patients with colorectal cancer: A potential
marker for colorectal cancer screening. Gut. 58:1375–1381. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu W, Li M, Chen X, Zhang D, Wei L, Zhang
Z, Wang S, Meng L, Zhu S and Li B: MicroRNA-373 promotes migration
and invasion in human esophageal squamous cell carcinoma by
inhibiting TIMP3 expression. Am J Cancer Res. 6:1–14.
2015.PubMed/NCBI
|
|
26
|
Yang F, Liu X, Liu Y, Liu Y, Zhang C, Wang
Z, Jiang T and Wang Y: miR-181d/MALT1 regulatory axis attenuates
mesenchymal phenotype through NF-κB pathways in glioblastoma.
Cancer Lett. 396:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shishodia G, Shukla S, Srivastava Y,
Masaldan S, Mehta S, Bhambhani S, Sharma S, Mehrotra R, Das BC and
Bharti AC: Alterations in microRNAs miR-21 and let-7a correlate
with aberrant STAT3 signaling and downstream effects during
cervical carcinogenesis. Mol Cancer. 14:1162015. View Article : Google Scholar : PubMed/NCBI
|
